Longboard Pharmaceuticals, Inc. (LBPH) Misses Q2 EPS by 12c
Tweet
Share
E-mailGet Alerts LBPH Hot Sheet
Join SI Premium – FREE
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) reported Q2 EPS of ($0.56), $0.12 worse than the analyst estimate of ($0.44).
For earnings history and earnings-related data on Longboard Pharmaceuticals, Inc. (LBPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Ionic Digital backs Texas data center audit amid grid reliability push
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
